【摘要】 目的 探讨介入联合双灵固本散治疗肝癌的临床效果。方法 100例肝癌患者随机分为两组：实验组为介入联合双灵固本散治疗50例，对照组为单纯介入治疗50例，两组的介入治疗方法相同。结果 试验组CR+PR为68%，对照组为48%(P<0.05)；缓解腹痛、乏力、纳差、腹水的有效率分别为82%、97%、93%、100%；栓塞后综合征明显减轻(P<0.01)，生活质量(按Karnofsky评分)明显提高(P<0.01)，肝功能及外周血白细胞数目改善(P<0.001)。结论 双灵固本散联合TACE术治疗肝癌可产生明显的协同抗肿瘤作用，减少术后副反应，对肝功能及骨髓的造血功能具有保护作用，显著提高患者生存质量，是整合治疗肝癌的最好办法。

    【关键词】 肝癌；双灵固本散；介入治疗

    The clinical research of Shuanglinggubensan therapy for hepatic cancer

    CAO Xi-cai,BAI Ren-ju,WANG Xiao-dong,et al.

    The Genernal Hospital,Tianjin Medical University,Tianjin 300052,China

    【Abstract】 Objective To research the efficacy of Shuanglinggubensan combined with interventional therapy in the treatment of hepatic cancer.Methods 100 patients with hepatic cancer were randomly divided into two groups,50 patients treated by Shuanglinggubensan combined with interventional therapy were divided as experimental group. 50 patients treatment only by interventional therapy were divided as control group.Results CR+PR were 68% in treatment group, and 48% in control group (P<0.05). In contrast to control group, the postchemoembolization syndrome was alleviated(P<0.05) ......